Abstract
The combination trimethoprim-sulfamethoxazole had no greater activity in a murine model of toxoplasmosis than did sulfamethoxazole alone.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Araujo F. G., Remington J. S. Effect of clindamycin on acute and chronic toxoplasmosis in mice. Antimicrob Agents Chemother. 1974 Jun;5(6):647–651. doi: 10.1128/aac.5.6.647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Domart A., Robineau M., Carbon C. La toxoplasmose acquise: une nouvelle chimiothérapie: l'association sulfamethoxazole-trimethoprime. Nouv Presse Med. 1973 Feb 3;2(5):321–322. [PubMed] [Google Scholar]
- Hibbs J. B., Jr, Lambert L. H., Jr, Remington J. S. Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. J Infect Dis. 1971 Dec;124(6):587–592. doi: 10.1093/infdis/124.6.587. [DOI] [PubMed] [Google Scholar]
- Norrby R., Eilard T., Svedhem A., Lycke E. Treatment of toxoplasmosis with trimethoprim-sulphamethoxazole. Scand J Infect Dis. 1975;7(1):72–75. doi: 10.3109/inf.1975.7.issue-1.13. [DOI] [PubMed] [Google Scholar]
- Sander J., Midtvedt T. The effect of trimethoprim on acute experimental toxoplasmosis in mice. Acta Pathol Microbiol Scand B Microbiol Immunol. 1970;78(6):664–668. doi: 10.1111/j.1699-0463.1970.tb04355.x. [DOI] [PubMed] [Google Scholar]